Is a complete EBS research report available?

No complete published report is available for Emergent BioSolutions Inc. (EBS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Emergent BioSolutions Inc. (EBS)

NYSE: EBS · USD

$7.03

+0.36 (+5.4%)· Recorded snapshot

Market cap	360.5M
Revenue (ttm)	770.2M
Net income (ttm)	-176.8M
EPS (ttm)	-$3.39
Shares out	51.3M
P/E (forward)	9.7x
Volume	651,925
Beta	2.29

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 770.2M
Net income (ttm): -176.8M
EPS (ttm): -$3.39
P/E (forward): 9.7x
Market cap: 360.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Metric	Value
Amount currency	USD
CIK code	0001367644
Company name	Emergent BioSolutions Inc.
Country	United States
Country code	US
CUSIP number	29089Q105
Earnings date	2026-11-02
Earnings time	amc
Employees	900
Employees change	-700
Employees growth	-43.75%
Enterprise value	$809M
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2006-11-15
Is primary listing	Yes
Is SPAC	No
ISIN number	US29089Q1058
Last 10-K release date	2026-02-27
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$360.5M
Market cap category	Small-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$7.03
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	EBS
U.S. state	Maryland
Website	https://www.emergentbiosolutions.com

Metric

Value

Amount currency

USD

CIK code

0001367644

Company name

Emergent BioSolutions Inc.

Country

United States

Country code

CUSIP number

29089Q105

Earnings date

2026-11-02

Earnings time

amc

Employees

900

Employees change

-700

Employees growth

-43.75%

Enterprise value

$809M

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1998

In index

RUSSELL2000

Industry

Drug Manufacturers - Specialty & Generic

IPO date

2006-11-15

Is primary listing

Yes

Is SPAC

ISIN number

US29089Q1058

Last 10-K release date

2026-02-27

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$360.5M

Market cap category

Small-Cap

Next earnings date

2026-11-02

Options

Yes

Price

$7.03

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

EBS

U.S. state

Maryland

Website

https://www.emergentbiosolutions.com

Metric	Value
Adjusted P/E ratio	4.88x
Average P/E ratio (10Y)	47.95x
Earnings yield	-48.18%
EV/EBIT	5.7x
EV/EBITDA	3.41x
EV/FCF	9.33x
EV/Sales	1.04x
FCF / EV yield	10.72%
FCF yield	24.35%
Forward EV/Sales	1.25x
Forward P/E	9.73x
Forward P/S	0.55x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(FCF - SBC) ratio	5.27x
P/(OCF - SBC) ratio	4.48x
P/B ratio	1x
P/FCF ratio	4.11x
P/OCF ratio	3.61x
P/S ratio	0.46x
Price / tangible book value	4.43x
Price/EBITDA ratio	1.5x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

4.88x

Average P/E ratio (10Y)

47.95x

Earnings yield

-48.18%

EV/EBIT

5.7x

EV/EBITDA

3.41x

EV/FCF

9.33x

EV/Sales

1.04x

FCF / EV yield

10.72%

FCF yield

24.35%

Forward EV/Sales

1.25x

Forward P/E

9.73x

Forward P/S

0.55x

Industry forward P/E

13.86x

Industry P/E

173.47x

P/(FCF - SBC) ratio

5.27x

P/(OCF - SBC) ratio

4.48x

P/B ratio

P/FCF ratio

4.11x

P/OCF ratio

3.61x

P/S ratio

0.46x

Price / tangible book value

4.43x

Price/EBITDA ratio

1.5x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	18.24%
EBITDA margin	30.5%
FCF margin	11.15%
Gross margin	50.44%
Operating margin	18.24%
Pretax margin	-18.96%
Profit margin	-22.96%
Profit per employee	$-196,444
Profitable years	1
Revenue per employee	$855,778
ROA	6.93%
ROA (5Y)	1.02%
ROCE	14.13%
ROE	-40.29%
ROE (5Y)	-19.53%
ROIC	16.18%
ROIC (5Y)	0.76%
SBC / revenue	2.45%
Tax / revenue	4%

Metric

Value

EBIT margin

18.24%

EBITDA margin

30.5%

FCF margin

11.15%

Gross margin

50.44%

Operating margin

18.24%

Pretax margin

-18.96%

Profit margin

-22.96%

Profit per employee

$-196,444

Profitable years

Revenue per employee

$855,778

ROA

6.93%

ROA (5Y)

1.02%

ROCE

14.13%

ROE

-40.29%

ROE (5Y)

-19.53%

ROIC

16.18%

ROIC (5Y)

0.76%

SBC / revenue

2.45%

Tax / revenue

Metric	Value
EPS growth years	2
FCF growth	-44.58%
FCF growth (Q)	-47.83%
FCF growth 5Y	-6.61%
Gross profit growth	-6.83%
Gross profit growth (Q)	109.82%
Gross profit growth 3Y	13.67%
Gross profit growth 5Y	-15.09%
Net income growth years	2
OCF growth	-42.19%
OCF growth (Q)	-47.27%
OCF growth 10Y	-4.07%
OCF growth 5Y	-21.4%
Operating income growth	17.87%
Operating income growth (Q)	5,433.33%
Operating income growth 5Y	-22.13%
Revenue growth	-9.56%
Revenue growth (Q)	66.29%
Revenue growth (QoQ)	50.1%
Revenue growth 10Y	4.16%
Revenue growth 3Y	-10.44%
Revenue growth 5Y	-14.73%
Revenue growth quarters	1
Revenue growth years	0

Metric

Value

EPS growth years

FCF growth

-44.58%

FCF growth (Q)

-47.83%

FCF growth 5Y

-6.61%

Gross profit growth

-6.83%

Gross profit growth (Q)

109.82%

Gross profit growth 3Y

13.67%

Gross profit growth 5Y

-15.09%

Net income growth years

OCF growth

-42.19%

OCF growth (Q)

-47.27%

OCF growth 10Y

-4.07%

OCF growth 5Y

-21.4%

Operating income growth

17.87%

Operating income growth (Q)

5,433.33%

Operating income growth 5Y

-22.13%

Revenue growth

-9.56%

Revenue growth (Q)

66.29%

Revenue growth (QoQ)

50.1%

Revenue growth 10Y

4.16%

Revenue growth 3Y

-10.44%

Revenue growth 5Y

-14.73%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-11.8M
Depreciation and amortization	$94.4M
EBIT	$140.5M
EBITDA	$234.9M
EPS	$-3.39
FCF per share	$1.68
Financing cash flow	$-165.6M
Free cash flow	$85.9M
Free cash flow minus SBC	$67M
Gross profit	$388.5M
Income taxes	$30.8M
Investing cash flow	$-62M
Net borrowing	$-117M
Net cash flow	$-130.1M
Net income	$-176.8M
Operating cash flow minus SBC	$78.8M
Operating income	$140.5M
Revenue	$770.2M
Stock-based compensation	$18.9M

Metric

Value

Capital expenditures

$-11.8M

Depreciation and amortization

$94.4M

EBIT

$140.5M

EBITDA

$234.9M

EPS

$-3.39

FCF per share

$1.68

Financing cash flow

$-165.6M

Free cash flow

$85.9M

Free cash flow minus SBC

$67M

Gross profit

$388.5M

Income taxes

$30.8M

Investing cash flow

$-62M

Net borrowing

$-117M

Net cash flow

$-130.1M

Net income

$-176.8M

Operating cash flow minus SBC

$78.8M

Operating income

$140.5M

Revenue

$770.2M

Stock-based compensation

$18.9M

Metric	Value
Altman Z-Score	1.65
Book value per share	$6.65
Debt / EBITDA	2.5
Debt / equity	1.72
Debt / FCF	6.85
Interest coverage	2.76
Long-term assets	$450.8M
Long-term liabilities	$652.6M
Net cash (debt)	$-448.5M
Net cash / market cap	-127.14%
Net debt / EBITDA	1.91
Net debt / equity	1.31
Net debt / FCF	5.22
Piotroski F-Score	6
Property, plant and equipment	$183.8M
Shareholders' equity	$341.4M
Tangible book value	$79.6M
Tangible book value per share	$1.55
Total assets	$1.1B
Total cash	$139.7M
Total debt	$588.2M
Total liabilities	$775.4M
WACC	10.58%

Metric

Value

Altman Z-Score

1.65

Book value per share

$6.65

Debt / EBITDA

2.5

Debt / equity

1.72

Debt / FCF

6.85

Interest coverage

2.76

Long-term assets

$450.8M

Long-term liabilities

$652.6M

Net cash (debt)

$-448.5M

Net cash / market cap

-127.14%

Net debt / EBITDA

1.91

Net debt / equity

1.31

Net debt / FCF

5.22

Piotroski F-Score

Property, plant and equipment

$183.8M

Shareholders' equity

$341.4M

Tangible book value

$79.6M

Tangible book value per share

$1.55

Total assets

$1.1B

Total cash

$139.7M

Total debt

$588.2M

Total liabilities

$775.4M

WACC

10.58%

Metric	Value
Asset turnover	0.61
Current assets	$666M
Current liabilities	$122.8M
Current ratio	5.42
Inventory turnover	1.19
Net working capital	$405M
Quick ratio	2.68
Working capital	$543.2M
Working capital turnover	1.36

Metric

Value

Asset turnover

0.61

Current assets

$666M

Current liabilities

$122.8M

Current ratio

5.42

Inventory turnover

1.19

Net working capital

$405M

Quick ratio

2.68

Working capital

$543.2M

Working capital turnover

1.36

Metric	Value
Buyback yield / dilution	5.35%
Dividend yield	0%
Shareholder yield	5.35%

Metric

Value

Buyback yield / dilution

5.35%

Dividend yield

Shareholder yield

5.35%

Metric	Value
10Y price change	-74.86%
10Y return CAGR	-12.9%
10Y total return	-74.86%
150-day SMA	$7.37
15Y price change	-64.84%
15Y return CAGR	-6.32%
15Y total return	-62.43%
1D price change	5.4%
1M price change	1.69%
1M total return	1.69%
1W price change	9.78%
1W total return	9.78%
1Y price change	-28.74%
1Y return CAGR	-28.76%
1Y total return	-28.74%
20-day SMA	$6.67
200-day SMA	$8.07
3M price change	-5.8%
3M total return	-5.8%
3Y price change	245.25%
3Y return CAGR	51.13%
3Y total return	245.25%
50-day SMA	$6.38
50-day SMA vs 200-day SMA	50under200
52-week high	$14.06
52-week high date	2026-01-07
52-week low	$4.36
52-week low date	2026-08-10
5Y price change	-85.68%
5Y return CAGR	-32.21%
5Y total return	-85.68%
6M price change	-14.01%
6M total return	-14.01%
All-time high	$137.61
All-time high date	2020-08-06
All-time low	$1.42
All-time low date	2024-02-06
Average true range (ATR)	$0.37
Average volume	1M
Beta (1Y)	1.03
Beta (2Y)	2.15
Beta (5Y)	2.29
Change from 52-week high	-50%
Change from 52-week low	61.24%
Change from all-time high	-94.98%
Change from all-time low	386.27%
Change from open	6.68%
Day's gap	-1.2%
Dollar volume	$4.6M
High price	$7.04
Low price	$6.58
Monthly RSI	43.54
Open price	$6.59
Position in 52-week range	97.83%
Premarket change	0.84%
Premarket close	$6.67
Premarket price	$6.73
Premarket volume	767
Previous close	$6.67
Price vs 150-day SMA	-6.26%
Price vs 20-day SMA	3.51%
Price vs 200-day SMA	-14.39%
Price vs 50-day SMA	8.19%
Relative volume	0.62
RSI	56.74
Sharpe ratio	-0.07
Sharpe ratio (3Y)	0.83
Sharpe ratio (5Y)	0.07
Sortino ratio	-0.03
Sortino ratio (3Y)	1.59
Sortino ratio (5Y)	0.18
Volume	651.9K
Weekly RSI	48.12
YTD price change	-44.13%
YTD total return	-44.13%

Metric

Value

10Y price change

-74.86%

10Y return CAGR

-12.9%

10Y total return

-74.86%

150-day SMA

$7.37

15Y price change

-64.84%

15Y return CAGR

-6.32%

15Y total return

-62.43%

1D price change

5.4%

1M price change

1.69%

1M total return

1.69%

1W price change

9.78%

1W total return

9.78%

1Y price change

-28.74%

1Y return CAGR

-28.76%

1Y total return

-28.74%

20-day SMA

$6.67

200-day SMA

$8.07

3M price change

-5.8%

3M total return

-5.8%

3Y price change

245.25%

3Y return CAGR

51.13%

3Y total return

245.25%

50-day SMA

$6.38

50-day SMA vs 200-day SMA

50under200

52-week high

$14.06

52-week high date

2026-01-07

52-week low

$4.36

52-week low date

2026-08-10

5Y price change

-85.68%

5Y return CAGR

-32.21%

5Y total return

-85.68%

6M price change

-14.01%

6M total return

-14.01%

All-time high

$137.61

All-time high date

2020-08-06

All-time low

$1.42

All-time low date

2024-02-06

Average true range (ATR)

$0.37

Average volume

Beta (1Y)

1.03

Beta (2Y)

2.15

Beta (5Y)

2.29

Change from 52-week high

-50%

Change from 52-week low

61.24%

Change from all-time high

-94.98%

Change from all-time low

386.27%

Change from open

6.68%

Day's gap

-1.2%

Dollar volume

$4.6M

High price

$7.04

Low price

$6.58

Monthly RSI

43.54

Open price

$6.59

Position in 52-week range

97.83%

Premarket change

0.84%

Premarket close

$6.67

Premarket price

$6.73

Premarket volume

767

Previous close

$6.67

Price vs 150-day SMA

-6.26%

Price vs 20-day SMA

3.51%

Price vs 200-day SMA

-14.39%

Price vs 50-day SMA

8.19%

Relative volume

0.62

RSI

56.74

Sharpe ratio

-0.07

Sharpe ratio (3Y)

0.83

Sharpe ratio (5Y)

0.07

Sortino ratio

-0.03

Sortino ratio (3Y)

1.59

Sortino ratio (5Y)

0.18

Volume

651.9K

Weekly RSI

48.12

YTD price change

-44.13%

YTD total return

-44.13%

Metric	Value
Float	49.1M
Float percentage	95.67%
Shares change (QoQ)	-8.67%
Shares change (YoY)	-5.35%
Shares held by insiders	4.33%
Shares held by institutions	88.82%
Shares outstanding	51.3M
Short % of float	18.95%
Short % of shares	18.13%
Short ratio	8.2 days

Metric

Value

Float

49.1M

Float percentage

95.67%

Shares change (QoQ)

-8.67%

Shares change (YoY)

-5.35%

Shares held by insiders

4.33%

Shares held by institutions

88.82%

Shares outstanding

51.3M

Short % of float

18.95%

Short % of shares

18.13%

Short ratio

8.2 days

Emergent BioSolutions Inc. (EBS)

Price

Financial snapshot

Fair-value bridge

Latest news · EBS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBS

Frequently asked questions